Riazi Sheila, Kraeva Natalia, Hopkins Philip M
From the Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada (S.R., N.K.); and the Department of Anaesthesia, University of Leeds, Leeds, United Kingdom (P.M.H.).
Anesthesiology. 2018 Jan;128(1):168-180. doi: 10.1097/ALN.0000000000001878.
This article reviews advancements in the genetics of malignant hyperthermia, new technologies and approaches for its diagnosis, and the existing limitations of genetic testing for malignant hyperthermia. It also reviews the various RYR1-related disorders and phenotypes, such as myopathies, exertional rhabdomyolysis, and bleeding disorders, and examines the connection between these disorders and malignant hyperthermia.
Anesthesiology. 2018-1
Anesthesiol Clin North Am. 2005-12
Neuromuscul Disord. 2013-4-28
Medicine (Baltimore). 2021-8-20
Anaesthesiol Intensive Ther. 2025-7-23
Clin Med Insights Case Rep. 2025-6-14
EClinicalMedicine. 2024-1-25
BMC Med Inform Decis Mak. 2023-9-5
BMJ Open Sport Exerc Med. 2016-9-7
Protein Sci. 2017-1
Semin Cell Dev Biol. 2016-8-8
BMC Med Genomics. 2016-8-11
Semin Cell Dev Biol. 2016-7-15